"Nebivolol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cardioselective ADRENERGIC BETA-1 RECEPTOR ANTAGONIST (beta-blocker) that functions as a VASODILATOR through the endothelial L-arginine/ NITRIC OXIDE system. It is used to manage HYPERTENSION and chronic HEART FAILURE in elderly patients.
| Descriptor ID |
D000068577
|
| MeSH Number(s) |
D02.033.100.291.491 D02.092.063.291.503 D03.383.663.283.755 D03.633.100.150.755
|
| Concept/Terms |
Nebivolol- Nebivolol
- Alpha,Alpha'-(Iminobis(Methylene))bis(6-Fluoro-3,4-dihydro)-2H-1-benzopyran-2-methanol
R 67555- R 67555
- 67555, R
- R-67555
- R67555
|
Below are MeSH descriptors whose meaning is more general than "Nebivolol".
Below are MeSH descriptors whose meaning is more specific than "Nebivolol".
This graph shows the total number of publications written about "Nebivolol" by people in this website by year, and whether "Nebivolol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Nebivolol" by people in Profiles.
-
Nebivolol reduces short-term blood pressure variability more potently than irbesartan in patients with intradialytic hypertension. Hypertens Res. 2019 07; 42(7):1001-1010.
-
A Critical Review of Nebivolol and its Fixed-Dose Combinations in the Treatment of Hypertension. Drugs. 2018 Nov; 78(17):1783-1790.
-
Outcomes of "diabetes-friendly" vs "diabetes-unfriendly" ß-blockers in older nursing home residents with diabetes after acute myocardial infarction. Diabetes Obes Metab. 2018 12; 20(12):2724-2732.
-
Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: a Danish nationwide cohort study. Eur J Heart Fail. 2018 03; 20(3):548-556.
-
Multicenter Randomized Double-Blind Comparison of Nebivolol plus HCTZ and Irbesartan plus HCTZ in the Treatment of Isolated Systolic Hypertension in Elderly Patients: Results of the NEHIS Study. Adv Ther. 2017 01; 33(12):2173-2187.
-
Nitric Oxide Contributes to Vasomotor Tone in Hypertensive African Americans Treated With Nebivolol and Metoprolol. J Clin Hypertens (Greenwich). 2016 Mar; 18(3):223-31.
-
Effect of antihypertensive therapy on endothelial markers in newly diagnosed stage 1 hypertension: a randomized single-centre study. Anadolu Kardiyol Derg. 2014 Jun; 14(4):363-9.